Stock Price
565.22
Daily Change
-4.87 -0.85%
Monthly
-7.52%
Yearly
-2.95%
Q1 Forecast
560.79

Thermo Fisher Scientific reported $9.91B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Agilent USD 1.42B 57M Sep/2025
Becton, Dickinson and Co. USD 5.07B 535M Sep/2025
Bio Techne USD 241.42M 2.52M Dec/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
Boston Scientific USD 4.03B 94M Sep/2025
Bruker USD 776.6M 8.9M Sep/2025
Charles River Laboratories USD 3.41B 2.51B Sep/2025
Danaher USD 5.34B 45.74B Dec/2025
Dentsply International USD 1.48B 653M Sep/2025
Edwards Lifesciences USD 1.13B 26.7M Sep/2025
Exact Sciences USD 875.74M 62.51M Sep/2025
General Electric Aerospace USD 10.94B 7.87B Dec/2025
Henry Schein USD 3.14B 77M Sep/2025
Hologic USD 349.4M 447.1M Dec/2025
Illumina USD 834M 20M Sep/2025
Intuitive Surgical USD 2B 263.6M Dec/2025
IQVIA Holdings USD 6.16B 2.7B Sep/2025
Laboratory Of America USD 3.17B 101.7M Sep/2025
Medtronic USD 7.26B 283M Sep/2025
Mettler Toledo International USD 735.5M 17.99M Sep/2025
Myriad Genetics USD 229M 3.4M Sep/2025
Olympus JPY 214.27B 24.11B Sep/2025
Quest Diagnostics USD 7.26B 4.94B Sep/2025
Repligen USD 176.13M 279K Sep/2025
Revvity USD 600.61M 12.7M Sep/2025
Stryker USD 5.2B 505M Dec/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
Veracyte USD 108.76M 7.09M Sep/2025
Waters USD 2.33B 1.75B Sep/2025
Zimmer Biomet Holdings USD 1.66B 17.8M Sep/2025